FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study).
Saved in:
| Title: | FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study). |
|---|---|
| Authors: | Hatachi Y; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kansai Rosai Hospital, Amagasaki, Japan., Mohan SR; Department of Artificial Intelligence, AI Medical and Health Tech Systems, Osaka, Japan., Kotake T; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kansai Electric Power Hospital, Osaka, Japan., Satake H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan., Okita Y; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kagawa University Hospital, Kagawa, Japan., Yasui H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan., Tsuji A; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kagawa University Hospital, Kagawa, Japan. |
| Source: | Cancer diagnosis & prognosis [Cancer Diagn Progn] 2022 Jan 03; Vol. 2 (1), pp. 101-106. Date of Electronic Publication: 2022 Jan 03 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35400007 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hatachi+Y%22">Hatachi Y</searchLink>; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kansai Rosai Hospital, Amagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Mohan+SR%22">Mohan SR</searchLink>; Department of Artificial Intelligence, AI Medical and Health Tech Systems, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kotake+T%22">Kotake T</searchLink>; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kansai Electric Power Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Satake+H%22">Satake H</searchLink>; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan.<br /><searchLink fieldCode="AU" term="%22Okita+Y%22">Okita Y</searchLink>; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kagawa University Hospital, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Yasui+H%22">Yasui H</searchLink>; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuji+A%22">Tsuji A</searchLink>; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kagawa University Hospital, Kagawa, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918316186306676%22">Cancer diagnosis & prognosis</searchLink> [Cancer Diagn Progn] 2022 Jan 03; Vol. 2 (1), pp. 101-106. <i>Date of Electronic Publication: </i>2022 Jan 03 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>9918316186306676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2732-7787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227327787%22">27327787 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Diagn Progn <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35400007 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21873/cdp.10083 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101 Titles: – TitleFull: FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hatachi Y – PersonEntity: Name: NameFull: Mohan SR – PersonEntity: Name: NameFull: Kotake T – PersonEntity: Name: NameFull: Satake H – PersonEntity: Name: NameFull: Okita Y – PersonEntity: Name: NameFull: Yasui H – PersonEntity: Name: NameFull: Tsuji A IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 01 Text: 2022 Jan 03 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2732-7787 Numbering: – Type: volume Value: 2 – Type: issue Value: 1 Titles: – TitleFull: Cancer diagnosis & prognosis Type: main |
| ResultId | 1 |
